摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis-4-[[3,5-bis(trifluoromethyl)benzyl]oxy]-3-phenylpiperidine hydrochloride

中文名称
——
中文别名
——
英文名称
cis-4-[[3,5-bis(trifluoromethyl)benzyl]oxy]-3-phenylpiperidine hydrochloride
英文别名
4-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-3-phenylpiperidine;hydrochloride;4-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-phenylpiperidine;hydrochloride
cis-4-[[3,5-bis(trifluoromethyl)benzyl]oxy]-3-phenylpiperidine hydrochloride化学式
CAS
——
化学式
C20H19F6NO*ClH
mdl
——
分子量
439.828
InChiKey
OUEMAHPTECCJLB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.81
  • 重原子数:
    29
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    21.3
  • 氢给体数:
    2
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    描述:
    cis-4-[[3,5-bis(trifluoromethyl)benzyl]oxy]-3-phenylpiperidine hydrochloride异氰酸甲酯三乙胺 作用下, 以 乙腈 为溶剂, 反应 14.0h, 以95%的产率得到cis-4-[[3,5-bis(trifluoromethyl)benzyl]oxy]-N-methyl-3-phenyl-1-piperidinecarboxamide
    参考文献:
    名称:
    EP1553084
    摘要:
    公开号:
  • 作为产物:
    描述:
    1-tert-butoxycarbonyl-4-(3,5-bis-trifluoromethyl-benzyloxy)-3-phenyl-piperidine 在 三氟乙酸盐酸 作用下, 以 乙酸乙酯 为溶剂, 反应 0.5h, 以47%的产率得到cis-4-[[3,5-bis(trifluoromethyl)benzyl]oxy]-3-phenylpiperidine hydrochloride
    参考文献:
    名称:
    EP1553084
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • Piperidine derivative, process for producing the same, and use
    申请人:Ikeura Yoshinori
    公开号:US20060167052A1
    公开(公告)日:2006-07-27
    The present invention provides a compound represented by the formula: wherein Ar is an aryl group, an aralkyl group or an aromatic heterocyclic group, each of which may be substituted, R 1 is a hydrogen atom, an optionally substituted hydrocarbon group, an acyl group or an optionally substituted heterocyclic group, X is an oxygen atom or an optionally lo substituted imino group, Z is an optionally substituted methylene group, Ring A is an optionally further substituted piperidine ring, and Ring B is an optionally substituted aromatic ring, provided that when Z is a methylene group substituted with an oxo group, R 1 is not a methyl group, and 15 when Z is a methylene group substituted with a methyl group, Ring B is a substituted aromatic ring, or a salt thereof, which is a novel piperidine derivative having excellent antagonistic action for a tachykinin receptor and useful as a medicament, particularly an agent for preventing and/or treating urinary frequency and/or urinary incontinence.
    本发明提供了一种化合物,其表示为以下式子:其中Ar是芳基、芳基烷基或芳香杂环基,每个基团都可以被取代,R1是氢原子、可选取代的碳氢基团、酰基或可选取代的杂环基团,X是氧原子或可选取代的亚胺基团,Z是可选取代的亚甲基团,环A是可选进一步取代的哌啶环,环B是可选取代的芳香环,但当Z是取代有氧基的亚甲基团时,R1不是甲基基团,而当Z是取代有甲基基团的亚甲基团时,环B是取代的芳香环,或其盐。该化合物是一种新型哌啶衍生物,具有优异的缓解速激肽受体拮抗作用,可用作药物,特别是用作预防和/或治疗尿频和/或尿失禁的药剂。
  • PIPERIDINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP1553084A1
    公开(公告)日:2005-07-13
    The present invention provides a compound represented by the formula:    wherein Ar is an aryl group, an aralkyl group or an aromatic heterocyclic group, each of which may be substituted, R1 is a hydrogen atom, an optionally substituted hydrocarbon group, an acyl group or an optionally substituted heterocyclic group, X is an oxygen atom or an optionally substituted imino group, Z is an optionally substituted methylene group, Ring A is an optionally further substituted piperidine ring, and Ring B is an optionally substituted aromatic ring, provided that when Z is a methylene group substituted with an oxo group, R1 is not a methyl group, and when Z is a methylene group substituted with a methyl group, Ring B is a substituted aromatic ring, or a salt thereof, which is a novel piperidine derivative having excellent antagonistic action for a tachykinin receptor and useful as a medicament, particularly an agent for preventing and/or treating urinary frequency and/or urinary incontinence.
    本发明提供了一种由式表示的化合物: 其中 Ar 是芳基、芳烷基或芳香杂环基团,每个基团均可被取代;R1 是氢原子、任选取代的烃基、酰基或任选取代的杂环基团;X 是氧原子或任选取代的亚氨基;Z 是任选取代的亚甲基;环 A 是任选进一步取代的哌啶环;环 B 是任选取代的芳香环、当 Z 是被氧代基团取代的亚甲基时,R1 不是甲基;当 Z 是被甲基取代的亚甲基时,环 B 是被取代的芳香环,或其盐,这是一种新型哌啶衍生物,对快速激肽受体有很好的拮抗作用,可用作药物,特别是预防和/或治疗尿频和/或尿失禁的药物。
  • US7622487B2
    申请人:——
    公开号:US7622487B2
    公开(公告)日:2009-11-24
  • EP1553084
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多